Amedisys Inc.

Momentum in equities should parlay into solid performance for larger cap healthcare names such as pharmacy benefit managers, labs and hospitals. In the report, Jefferies writes, “We continue to believe that [Quest Diagnostics] DGX, [Express Scripts, Inc.] ESRX, [Medco Health Solutions, Inc.] MHS (...

Shares of Amedisys Inc. (Nasdaq: AMED) hit a 52 week high, before falling and trading below yesterday's closing price of $60.04. The home nursing provider reported a 43% jump in quarterly profits, beating Wall Street expectations. Amedisys earned $37.8 million, or $1.35 per share, up from $26.3...